SFL attends event on Clinical trial strategy
SFL’s Director of Regulatory Affairs Suzanne Einmahl and Director of Medical Affairs Daniela Kenzelmann Broz will attend the Swiss Biotech Insight event on “Clinical trial strategy: Fine-tuning the risk-reward profile” (19 September 2019, Lausanne). The event hosts speakers discussing strategies in developing innovative clinical products from idea to proof-of-concept, harnessing new technologies in drug development, changing regulatory frameworks and future opportunities in drug development.
SFL provides both strategic as well as operational support for projects covering all life-cycle stages from early development to regulatory maintenance and commercialization of approved healthcare products, utilizing its unique combination of expertise and a multi-disciplinary approach. Contact us to arrange a meeting to discuss how SFL can support your projects.